Abstract:Objective: To investigate the mechanism of Lycium barbarum polysaccharides（LBP） in promoting the activation of RAW264.7 macrophages. Method: RAW264.7 macrophages were stimulated with LBP at different concentrations(50, 100, 200 mg·L -1 ), and those stimulated with lipopolysaccharide（LPS） at 100 μg·L -1 and galactose（Gal） at 100 mg·L -1 as positive controls. After 24 h of LBP stimulation, the cell counting kit-8（CCK-8） was used to detect the survival rate of RAW264.7 macrophages treated with LBP(0, 50, 100, 200, 400, 800 mg·L -1 ). The levels of interleukin-6（IL-6） and interleukin-12（IL-12） in cell culture supernatant were detected by enzyme-linked immunosorbent assay（ELISA）. The protein and mRNA expression of p38 mitogen-activated protein kinase（MAPK）, extracellular signal-regulated kinase（ERK）, c-Jun N-terminal kinase（JNK）, and nuclear factor κB（NF-κB） in Toll-like receptor 4（TLR4）/Toll-like receptor 2（TLR2）/macrophage galactose-type lectin（MGL） pathway of RAW264.7 macrophages was detected by Realtime fluorescence-based quantitative polymerase chain reaction（Real-time PCR） and Western blot. Result: CCK-8 results showed that compared with the results in the blank group, the survival rate of RAW264.7macrophages decreased in the 400, 800 mg·L -1 LBP groups（P＜0.05）. ELISA results showed that compared with the blank group, 50 mg·L -1 LBP could promote the secretion of IL-12 in RAW264.7 macrophages（P＜0.01）.Compared with the blank group, 100 mg·L -1 LBP and 200 mg·L -1 LBP could promote the secretion of IL-6 in RAW264.7 macrophages（P＜0.05, P＜0.01）. Western blot results showed that compared with the blank group, the LBP groups(50, 100, 200 mg·L -1 ) enhanced protein expression levels of MAPK key molecules（p-p38MAPK, p-ERK, p-NF-κB, and p-JNK） in TLR4, TLR2, and MGL pathways（P＜0.05, P＜0.01）. Compared with the model group, the 200 mg·L -1 LBP group could promote the expression level of p-NF-κB protein in RAW264.7 macrophages（P＜0.01）. Real-time PCR results showed that compared with the blank group, the LBP groups(50, 100, and 200 mg·L -1 ) enhanced the mRNA expression levels of MAPK key molecules（p38MAPK, ERK, NF-κB, and JNK） in TLR4 and TLR2 pathways（P＜0.05, P＜0.01）. Compared with the model group, the 50 and 200 mg·L -1 LBP groups could promote the mRNA expression levels of JNK and ERK2 in RAW264.7 macrophages（P＜0.05, P＜0.01）. Conclusion: LBP can regulate the activation of RAW264.7macrophages and participate in the immune response through the TLR2/TLR4/MGL pathway.

Lipoxin A 4 Inhibits NF-κB Activation and Cell Cycle Progression in RAW264.7 Cells

Lipoxin A4 Negatively Regulates Lipopolysaccharide-Induced Differentiation of RAW264.7 Murine Macrophages into Dendritic-Like Cells.

Effect of LX A4 and BML-111 on TLR4/NF-κB Signaling Pathway in Macrophage

Lipoxin A4 Inhibits Lipopolysaccharide-induced Differentiation of RAW264.7 Murine Macrophages into Dendritic-like Cells and Its Maturation

Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2–IRF pathway

Effects of Lipoxin A 4 on Lipopolysaccharide Induced Proliferation and Reactive Oxygen Species Production in RAW264.7 Macrophages Through Modulation of G-CSF Secretion

Effects of Lipoxin A_4 on Expression of G-CSF and Possible Mechanisms

The Atheroprotective Role of Lipoxin A4 Prevents Oxldl-Induced Apoptotic Signaling in Macrophages Via JNK Pathway.

Inhibition of Lipopolysaccharide-Stimulated No Production by A Novel Synthetic Compound Cyl-4d in Raw 264.7 Macrophages Involving the Blockade of Mek4/Jnk/Ap-1 Pathway

Lipoxin A4 Inhibits Jurkat T Cell Activation and Proliferation by Blocking Calcium Entry Current Isoc

LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice

Lipoxin A4 Regulates Lipopolysaccharide-Induced BV2 Microglial Activation and Differentiation Via the Notch Signaling Pathway.

Effects of Lipoxin A_4 on Lipopolysaccharide-induce Oxidative Damage in Macrophage

Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss

Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells.

Lycium barbarum Polysaccharide Regulates Activation of RAW264.7 Macrophages Through MGL/TLR Pathway

Lipoxin A4 Inhibited the Activation of Hepatic Stellate Cells -T6 Cells by Modulating Profibrotic Cytokines and NF-κB Signaling Pathway.

The P38 MAPK Inhibitor JLU1124 Inhibits the Inflammatory Response Induced by Lipopolysaccharide Through the MAPK-NF-κB Pathway in RAW264.7 Macrophages.

Lipoxin A4 and Its Analog Suppress Hepatocellular Carcinoma Via Remodeling Tumor Microenvironment

Lipid Mediator Lipoxin A4 Inhibits Tumor Growth by Targeting IL-10-producing Regulatory B (breg) Cells.

Lipoxin A 4 Inhibits 5-Lipoxygenase Translocation and Leukotrienes Biosynthesis to Exert a Neuroprotective Effect in Cerebral Ischemia/Reperfusion Injury